Journal article
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol
Journal of clinical oncology, Vol.7(1), pp.58-66
01/1989
DOI: 10.1200/JCO.1989.7.1.58
PMID: 2642541
Abstract
Fifty-nine consecutive previously untreated adult patients with acute lymphoblastic leukemia (ALL) were entered onto a prospective single-arm trial of doxorubicin, vincristine, prednisone, and asparaginase (HOP-L) induction therapy followed by CNS prophylaxis and 3 years of maintenance therapy. Consolidation therapy was not administered. The study population included a large number of older (greater than 50 years) patients. Seventy-five percent of patients achieved complete remission. With a median follow-up of 6 years, the median duration of complete remission is greater than 4 years, with 53% of patients expected to remain in remission at both 3 and 5 years. Overall, median survival duration is 27.9 months, with 45% and 35% of all patients expected to survive 3 and 5 years, respectively. Multivariate analysis identified patients with T-cell disease and mediastinal masses (P less than .001) and those with low values of lactic dehydrogenase (LDH) (P = .057) as being at greatest risk of relapse. Therapy was well tolerated by patients under age 35, but older patients suffered appreciable mortality. We conclude that this treatment program is effective therapy for adult ALL, yielding a large proportion of durable remissions despite the exclusion of consolidation therapy.
Details
- Title: Subtitle
- Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol
- Creators
- James E Radford JrC Patrick BurnsMichael P JonesRoger D GingrichJohn D KempRichard W EdwardsDavid B McFaddenFred R DickB.-Chen Wen
- Resource Type
- Journal article
- Publication Details
- Journal of clinical oncology, Vol.7(1), pp.58-66
- Publisher
- United States
- DOI
- 10.1200/JCO.1989.7.1.58
- PMID
- 2642541
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Grant note
- RR59 / NCRR NIH HHS 5T32 HL-7344 / NHLBI NIH HHS
- Language
- English
- Date published
- 01/1989
- Academic Unit
- Statistics and Actuarial Science; Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Biostatistics; Public Policy Center (Archive); Internal Medicine
- Record Identifier
- 9983985968702771
Metrics
23 Record Views